Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Von Schenker, Erhard
and
Herbst, Horst
1963.
Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques.
p.
269.
Lal, S.
and
Nair, N. P. V.
1992.
Is levomepromazine a useful drug in treatment‐resistant schizophrenia?.
Acta Psychiatrica Scandinavica,
Vol. 85,
Issue. 3,
p.
243.
Nair, N. P. V.
Cecyre, D.
Quirion, R.
and
Lal, S.
1993.
Levomepromazine receptor binding profile in human brain—implications for treatment—resistant schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 87,
Issue. 6,
p.
380.
Thornley, B
Rathbone, J
Adams, CE
Awad, G
and
Thornley, Ben
2003.
Cochrane Database of Systematic Reviews.
Lal, Samarthji
Thavundayil, Joseph X.
Nair, N.P. Vasavan
Annable, Lawrence
Ng Ying Kin, Ng M.K.
Gabriel, Antoine
and
Schwartz, George
2006.
Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
Journal of Psychiatry and Neuroscience,
Vol. 31,
Issue. 4,
p.
271.
Adams, Clive E
Awad, George
Rathbone, John
Thornley, Ben
and
Adams, Clive E
2007.
Cochrane Database of Systematic Reviews.
Sivaraman, Parthipan
Rattehalli, Ranganath D
and
Jayaram, Mahesh B
2010.
Levomepromazine for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2013,
Issue. 2,
eLetters
No eLetters have been published for this article.